AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Asrapan-IV Injection

Prescription Icon
Prescription Required

Marketer

Asrawell Lifecare

Salt Composition

Pantoprazole (40mg)

Overview Asrapan-IV Injection

Intravenous Asrapan reduces gastric acid production, treating stomach and intestinal acid-related disorders like acid reflux, peptic ulcers, and Zollinger-Ellison syndrome. It alleviates symptoms, promotes healing, and prevents stress ulcers in critically ill patients, often pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this medication is administered intravenously by a healthcare provider only when deemed necessary over oral alternatives. Dosage and treatment duration are determined by your physician based on individual needs and response. Optimal results are achieved by consuming smaller, more frequent meals and avoiding caffeine, spicy, and fatty foods. Common, typically mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, stomach pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use, particularly exceeding one year or with higher doses, may increase bone fracture risk. Discuss bone health (osteoporosis) prevention strategies, such as calcium and vitamin D supplementation, with your doctor. Asrapan-IV is contraindicated in individuals with severe liver disease, those on HIV medications, those with prior allergic reactions to similar drugs, or those with osteoporosis. Pregnant or lactating women should consult their physician. Alcohol consumption should be avoided due to its acid-stimulating properties. Refrain from operating machinery if dizziness or drowsiness occurs.

Uses of Asrapan-IV Injection

Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.

Major Benefits of Asrapan-IV Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Asrapan-IV Injection:

  • Diarrhea
  • Flatulence
  • Headache
  • Joint pain
  • Nausea
  • Stomach pain
  • Vomiting
  • Dizziness
  • Thrombophlebitis

How to use Asrapan-IV Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Asrapan-IV Injection works:

Asrapan-IV Injection, a proton pump inhibitor, decreases stomach acid production, thereby alleviating heartburn and acid indigestion.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Asrapan-IV Injection should not be used concurrently with alcohol consumption.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Asrapan-IV Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to any prescription. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers may likely use Asrapan-IV Injection without significant risk to their infants. Available data from human studies indicate minimal danger to the nursing child.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Asrapan-IV Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Asrapan-IV Injection presents no safety concerns for patients with renal impairment; no dosage modification is necessary.

LiverLiverCAUTION

Patients with significant hepatic impairment should receive Asrapan-IV Injection with close monitoring. The Asrapan-IV Injection dosage might require modification. Physician consultation is advised.

What if you forget to take Asrapan-IV Injection :

Should you inadvertently omit a scheduled dose of Asrapan-IV Injection, seek medical advice from your physician.

Facts to Know About Asrapan-IV Injection

LabelValue
Type of Compound Benzimidazole sulfoxide analog
Potential for Dependence None.
Medication Classification Gastrointestinal tract
Mechanism of Action Gastric acid secretion suppressants

FAQs on Asrapan-IV Injection

Intravenous Asrapan is indicated for managing peptic ulcers, reflux esophagitis, and gastroesophageal reflux disease (GERD). This injection counteracts the increased acidity often caused by analgesic medications. Furthermore, it's employed in the treatment of Zollinger-Ellison syndrome (ZES), a condition characterized by excessive gastric acid secretion. The therapeutic mechanism involves decreasing stomach acid production, thereby alleviating associated symptoms.
Concurrent use of antacids and Asrapan-IV Injection is permissible. Administer antacids at least two hours prior to or following Asrapan-IV Injection.
Noticeable improvement should occur within 2 to 3 days. However, full therapeutic effect with Asrapan-IV Injection may require up to four weeks; some symptoms might persist until then.
Prolonged Asrapan-IV Injection therapy, while infrequent, can sometimes lead to increased body weight. This may be attributed to improved reflux symptoms, potentially increasing appetite. Discuss any weight concerns with your physician.
Consuming alcohol while using Asrapan-IV Injection is discouraged. While alcohol doesn't directly interfere with the injection's mechanism, it can elevate stomach acid levels, potentially exacerbating existing symptoms.
Administering Asrapan-IV Injection is optimally performed one hour prior to food consumption. Patients should exclude spicy and high-fat foods from their diet during treatment. The consumption of caffeinated beverages, including tea, coffee, and cola, is strictly prohibited. Similarly, alcoholic beverages should be omitted, as their ingestion may exacerbate existing symptoms.
Asrapan-IV Injection is typically administered for short-term treatment. Nevertheless, its use may extend to longer durations in specific situations, including the management of peptic ulcer disease and Zollinger-Ellison syndrome. Prolonged therapy increases the potential for adverse reactions and necessitates close medical oversight. Always adhere to your physician's instructions and remain under their care when using Asrapan-IV Injection.
Concurrent use of painkillers and Asrapan-IV Injection is considered safe. Asrapan-IV Injection offers protection against the stomach upset and ulcers that can result from painkiller use. Asrapan-IV Injection should be administered one hour prior to meals, while painkillers are typically best tolerated when ingested with or following a meal.
A single dose of Asrapan-IV Injection may prove inadequate. Relief from symptoms often occurs after only a few administrations. Generally, Asrapan-IV Injection is used short-term, up to two weeks, for conditions such as heartburn, indigestion, and acid reflux. Nevertheless, longer-term use might be prescribed for conditions like peptic ulcer disease and Zollinger-Ellison syndrome (ZES). If symptoms persist after two weeks of regular use as directed, consult your physician.
Extended Asrapan-IV Injection use beyond three months can lead to adverse effects. Prolonged administration may result in hypomagnesemia, manifesting as fatigue, confusion, dizziness, tremors, or muscle spasms, and potentially irregular heartbeat. Treatment exceeding one year increases the risk of bone fragility, gastrointestinal infections, and vitamin B12 deficiency. This deficiency can cause anemia, characterized by weariness, weakness, pallor, palpitations, dyspnea, lightheadedness, dyspepsia, anorexia, flatulence, or neurological symptoms including paresthesia and gait disturbances.
Asrapan-IV Injection
41
MRP 50
18% off